Roth Capital Partners (Roth MKM), a relationship-driven investment bank dedicated to serving growth companies and their investors, is partnering with IBN as an official media sponsor for this week’s third annual Roth Healthcare Opportunities Conference. The invitation-only, one-day conference is scheduled for Oct. 9, 2024, in New York City. According to the announcement, IBN will leverage its extensive corporate communications network to increase awareness of the conference, which is an exclusive platform that gathers together veteran investors with C-suite executives from public and private companies in the healthcare sector.
“ROTH’s upcoming conference is set to showcase some of the most promising innovations in the healthcare sector,” said IBN director of global operations Randy Clark in the press release. “Our ongoing partnership with ROTH allows us to leverage our comprehensive communications capabilities, helping industry stakeholders stay informed and engaged. We’re excited to work closely with ROTH’s outstanding team to support this event.”
To find out more about the conference, visit https://ibn.fm/h75RE
To view the full press release, visit https://ibn.fm/nSRCE
About Roth Capital Partners LLC
Roth Capital Partners is a relationship-driven investment bank focused on serving growth companies and their investors. As a full-service investment bank, Roth provides capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory and corporate access. Headquartered in Newport Beach, California, Roth is a privately held, employee-owned organization that maintains offices throughout the United States. For more information about this company, please visit www.Roth.com.
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
